Cite
MLA Citation
Ray Kim et al.. “IDDF2020-ABS-0057 Risk of incident hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) virus-infected patients treated with tenofovir disoproxil fumarate (TDF) versus entecavir (ETV): a US administrative claims analysis.” Gut, vol. 69, n.d., p. A73. http://access.bl.uk/ark:/81055/vdc_100137788179.0x00004c